6,827 press releases indexed under healthcare.
OSLO, Norway & BOSTON, September 01, 2026--Calluna Pharma Announces Participation in Upcoming Conferences to highlight Phase 2 AURORA study of CAL101 in IPF ahead of planned Q1 2027 readout
(PR-inside.com) Leading physicians, scientists, regulatory experts, and healthcare innovators will convene October 23-25 at Fort Lauderdale's Pier Sixty-Six Resort + Marina for three days of regenerative medicine education, hands-on clinical training, and interdisciplinary collaboration FORT LAUDERDALE, FL / ACCESS Newswire / September 1, 2026 / ZEO ScientifiX, Inc. (OTCQB:ZEOX) ("ZEO ScientifiX" or the "Company") today announced the multidisciplinary faculty and guest speaker lineup for the inaugural ZEO Xperience, a three-day immersive regenerative medicine event for healthcare professionals taking place October 23-25, 2026, at Pier Sixty-Six Resort + Marina in Fort Lauderdale, Florida. Bringing together physicians, scientists, regulatory professionals, clinical educators, and healthcare
(PR-inside.com) Regulatory Executive Brings More Than 15 Years of FDA, Medical Device, SaMD, and Digital Health Experience to Support AIML's Medical Device Strategy TORONTO, ON / ACCESS Newswire / September 1, 2026 / AI/ML Innovations Inc. ("AIML" or the "Company") (CSE:AIML)(OTCQB:AIMLF)(FWB:42FB), a company advancing artificial intelligence and neural-network-based technologies for digital health, is pleased to announce that its wholly owned subsidiary, NeuralCloud Solutions Inc. ("NeuralCloud"), has appointed Dr. Mehmet A. Kosoglu, Ph.D., as Head of Regulatory. Dr. Kosoglu is a former U.S. Food and Drug Administration ("FDA") lead reviewer and scientist with more than 15 years of experience spanning medical device development, biotechnology, ..
(PR-inside.com) The Best Online PRP Course is the AACM PRP & PRF Certification Program SEATTLE, WA / ACCESS Newswire / September 1, 2026 / Among the online training options available, the American Academy of Cosmetic Medicine (AACM) is the best choice for medical professionals seeking structured, self-paced education in platelet-rich plasma (PRP) and platelet-rich fibrin (PRF) therapies for only $299, and it is accredited for 3 hours of continuing medical education credits. The course is accredited by the Accreditation Council for Continuing Medical Education (ACCME) , the Accreditation Council for Pharmacy Education (ACPE) , and the American Nurses Credentialing Center (ANCC) , and ..
(PR-inside.com) Insurance coverage for gender affirming surgeries is accepted by Dr. Sajan SEATTLE, WA / ACCESS Newswire / September 1, 2026 / For transgender and nonbinary patients considering gender affirming surgery, insurance can be an important factor when choosing a surgeon. Dr. Javad Sajan of Allure Esthetic Plastic Surgery accepts private insurance for transgender and gender affirming surgeries and is in-network with most private insurance carriers. His practice offers a range of gender affirming procedures, including FTM top surgery , MTF breast augmentation , body contouring , tracheal shave procedures , and other surgical options based on each patient's goals. Insurance coverage for ..
(PR-inside.com) Peru becomes the newest addition to Cellgenic's Latin American commercial network - one of three coordinated market initiatives across the region, subject to applicable local regulatory requirements. MIAMI, FL / ACCESS Newswire / September 1, 2026 / Regenerative Medical Technology Group, Inc. (the "Company" or "RMTG") (OTCID:RMTG), a regenerative medicine company operating through its wholly owned subsidiary Global Stem Cells Group, today announced the commencement of Cellgenic commercial activity in Peru through the establishment of local commercial arrangements, including exclusive representation arrangements in permitted channels. The Peru announcement extends Cellgenic's Latin American commercial network, which the Company has been building through market ..
REDWOOD CITY, Calif., September 01, 2026--Adicet Bio, Inc. (Nasdaq: ACET), a clinical stage biotechnology company discovering and developing allogeneic gamma delta CAR-T cell and in vivo CAR-T therapies for autoimmune diseases, hematologic malignancies and solid tumors, today announced completion of the last patient visit for the planned Phase 1 safety and efficacy analysis of prulacabtagene leucel (prula-cel) in patients with systemic lupus erythematosus (SLE) with or without lupus nephritis (L
Certified Nature Based Counselor brings trauma-informed, neurodivergent-affirming and creativity-centered support to adults and adolescents
WATERTOWN, Mass., September 01, 2026--Enanta Pharmaceuticals, Inc. (NASDAQ:ENTA), a clinical-stage biotechnology company dedicated to creating small molecule drugs for viral infections and immunological diseases, today announced that members of management will participate in two investor conferences in September:
Leading physicians, scientists, regulatory experts, and healthcare innovators will convene October 23-25 at Fort Lauderdale's Pier Sixty-Six Resort + Marina for three days of regenerative medicine education, hands-on clinical training, and interdisciplinary collaboration
WALTHAM, Mass., Sept. 1, 2026 /PRNewswire/ -- Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing innovative therapies for alopecia areata ("AA") and other autoimmune and inflammatory diseases, today announced that management will...
Strong start to fiscal year with net sales of $843 million growing 17% as reported and 16% organic U.S. net sales growth accelerated to 13%; continued robust international net sales growth of 18% as reported, 17% organic Advanced global pipeline ahead of schedule with FDA submission for...